<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zou J</submitter><funding>China Scholarship Council</funding><funding>Central People&amp;apos;s Government of the People&amp;apos;s Republic of China Scholarship Programme</funding><funding>European Research Council</funding><funding>Horizon 2020 Framework Programme</funding><pagination>107899</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11742345</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>300(12)</volume><pubmed_abstract>Agonist-induced rises in cytosolic Ca&lt;sup>2+&lt;/sup> control most platelet responses in thrombosis and hemostasis. In human platelets, we earlier demonstrated that the ORAI1-STIM1 pathway is a major component of extracellular Ca&lt;sup>2+&lt;/sup> entry, in particular when induced via the ITAM-linked collagen receptor, glycoprotein VI (GPVI). In the present article, using functionally defective platelets from patients with a loss-of-function mutation in ORAI1 or STIM1, we show that Ca&lt;sup>2+&lt;/sup> entry induced by the endoplasmic reticulum ATPase inhibitor, thapsigargin, fully relies on this pathway. We demonstrate that both the GPVI-induced and thapsigargin-induced Ca&lt;sup>2+&lt;/sup> entry are strongly suppressed by protein kinase C (PKC) activation while leaving intracellular Ca&lt;sup>2+&lt;/sup> mobili</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>Suppressed ORAI1-STIM1-dependent Ca&amp;lt;sup&amp;gt;2+&amp;lt;/sup&amp;gt; entry by protein kinase C isoforms regulating platelet procoagulant activity.</pubmed_title><pmcid>PMC11742345</pmcid><funding_grant_id>813409</funding_grant_id><funding_grant_id>201909370052</funding_grant_id><pubmed_authors>Provenzale I</pubmed_authors><pubmed_authors>Zou J</pubmed_authors><pubmed_authors>Solari FA</pubmed_authors><pubmed_authors>Jurk K</pubmed_authors><pubmed_authors>Kuijpers MJE</pubmed_authors><pubmed_authors>Sickmann A</pubmed_authors><pubmed_authors>Zieger B</pubmed_authors><pubmed_authors>Zhang P</pubmed_authors><pubmed_authors>Swieringa F</pubmed_authors><pubmed_authors>Mattheij NJA</pubmed_authors><pubmed_authors>Schonichen C</pubmed_authors><pubmed_authors>Rauch JS</pubmed_authors><pubmed_authors>Heemskerk JWM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Suppressed ORAI1-STIM1-dependent Ca&amp;lt;sup&amp;gt;2+&amp;lt;/sup&amp;gt; entry by protein kinase C isoforms regulating platelet procoagulant activity.</name><description>Agonist-induced rises in cytosolic Ca&lt;sup>2+&lt;/sup> control most platelet responses in thrombosis and hemostasis. In human platelets, we earlier demonstrated that the ORAI1-STIM1 pathway is a major component of extracellular Ca&lt;sup>2+&lt;/sup> entry, in particular when induced via the ITAM-linked collagen receptor, glycoprotein VI (GPVI). In the present article, using functionally defective platelets from patients with a loss-of-function mutation in ORAI1 or STIM1, we show that Ca&lt;sup>2+&lt;/sup> entry induced by the endoplasmic reticulum ATPase inhibitor, thapsigargin, fully relies on this pathway. We demonstrate that both the GPVI-induced and thapsigargin-induced Ca&lt;sup>2+&lt;/sup> entry are strongly suppressed by protein kinase C (PKC) activation while leaving intracellular Ca&lt;sup>2+&lt;/sup> mobili</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-22T05:22:37.512Z</modification><creation>2025-04-05T21:19:35.243Z</creation></dates><accession>S-EPMC11742345</accession><cross_references><pubmed>39424145</pubmed><doi>10.1016/j.jbc.2024.107899</doi></cross_references></HashMap>